Bunkerhill ECG-EF vs Reveal LINQ Insertable Cardiac Monitor
AI Verdict
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if you need a rapid, non-invasive screening tool to identify patients at risk for reduced left ventricular ejection fraction (LVEF ≤ 40%) from routine 12-lead ECGs. This software-only solution is ideal for early identification of potential heart failure in a broad clinical setting, integrating seamlessly with existing EHRs for automated workflows.
View Bunkerhill ECG-EF →Choose Reveal LINQ Insertable Cardiac Monitor if…
Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous cardiac monitoring to diagnose intermittent arrhythmias such as atrial fibrillation or unexplained syncope that are challenging to capture with conventional methods. This implantable device offers extended battery life and AI-powered algorithms to reduce false alerts, providing a high diagnostic yield over several years.
View Reveal LINQ Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | Reveal LINQ Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Contact sales for pricing details. | Contact vendor |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill ECG-EFBunkerhill ECG-EF is a non-invasive, software-only solution that integrates directly into existing EHR workflows, making it highly usable for clinicians and patients alike. In contrast, the Medtronic Reveal LINQ ICM is an implantable device that requires a surgical procedure and ongoing patient engagement with a mobile app or home communicator for data transmission, adding layers of complexity.
Clinical Value
Reveal LINQ Insertable Cardiac MonitorWhile both offer significant clinical value, the Medtronic Reveal LINQ ICM provides continuous, long-term monitoring for up to 4.5 years, which is crucial for diagnosing intermittent arrhythmias and syncope that might otherwise be missed. Bunkerhill ECG-EF offers valuable early screening for LVEF from routine ECGs, but its diagnostic window is limited to the point of ECG capture.
Pricing & Value
Bunkerhill ECG-EFWhile specific pricing is not disclosed for either, Bunkerhill ECG-EF is a software-only solution, which generally implies a lower acquisition cost and potentially a more flexible subscription model. The Medtronic Reveal LINQ ICM is an implantable medical device, inherently involving higher costs due to the device itself, the surgical procedure, and associated long-term monitoring services.
Enterprise Readiness
Bunkerhill ECG-EFBoth tools demonstrate strong foundational enterprise readiness with FDA clearance, HIPAA compliance, and BAA availability. However, Bunkerhill ECG-EF's software-only nature and seamless EHR integration make it simpler to deploy and manage across an enterprise without the additional logistical complexities of managing implantable devices and patient-facing hardware.
Innovation
Bunkerhill ECG-EFBunkerhill ECG-EF represents a more disruptive innovation by enabling the detection of reduced LVEF from a standard, routine ECG, potentially transforming early heart failure screening. While Medtronic's AccuRhythmu2122 AI is innovative in improving the accuracy of existing ICM technology, Bunkerhill's approach offers a fundamentally new diagnostic capability from widely available data.
Support & Docs
Reveal LINQ Insertable Cardiac MonitorMedtronic offers a robust and well-documented support ecosystem, including dedicated technical and patient service phone lines, extensive device manuals, and patient education materials. In contrast, specific details regarding dedicated support channels or comprehensive documentation for Bunkerhill ECG-EF were not readily available in the provided information or web search.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | Reveal LINQ Insertable Cardiac Monitor |
|---|---|---|
| Name | Bunkerhill ECG-EF | Reveal LINQ Insertable Cardiac Monitor |
| Company | BunkerHill Health | Medtronic |
| Primary AI Function | Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from 12-lead ECGs | Reduces false alerts and enhances diagnostic yield for conditions like atrial fibrillation and syncope using deep learning AI |
| Device Type | Software-only medical device | Implantable device |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pediatrics |
| Key AI Algorithm | AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause) |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and Reveal LINQ Insertable Cardiac Monitor.